Annual CFO
-$42.64 M
-$12.52 M-41.58%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual cash flow from operations is currently -$42.64 million, with the most recent change of -$12.52 million (-41.58%) on 31 December 2023. During the last 3 years, it has fallen by -$39.84 million (-1421.26%). ACRV annual CFO is now -1421.26% below its all-time high of -$2.80 million, reached on 01 December 2020.ACRV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$17.32 M
-$3.42 M-24.60%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly cash flow from operations is currently -$17.32 million, with the most recent change of -$3.42 million (-24.60%) on 30 September 2024. Over the past year, it has dropped by -$7.52 million (-76.66%). ACRV quarterly CFO is now -197.44% below its all-time high of -$5.82 million, reached on 01 June 2022.ACRV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$60.67 M
-$7.52 M-14.14%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock TTM cash flow from operations is currently -$60.67 million, with the most recent change of -$7.52 million (-14.14%) on 30 September 2024. Over the past year, it has dropped by -$21.05 million (-53.11%). ACRV TTM CFO is now -620.78% below its all-time high of -$8.42 million, reached on 01 March 2022.ACRV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.6% | -76.7% | -53.1% |
| 3 y3 years | -1421.3% | - | - |
| 5 y5 years | - | - | - |
ACRV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1421.3% | at low | -197.4% | at low | -620.8% | at low |
| 5 y | 5 years | -1421.3% | at low | -197.4% | at low | -620.8% | at low |
| alltime | all time | -1421.3% | at low | -197.4% | at low | -620.8% | at low |
Acrivon Therapeutics Common Stock Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.32 M(+24.6%) | -$60.67 M(+14.1%) |
| June 2024 | - | -$13.90 M(-18.6%) | -$53.16 M(+9.9%) |
| Mar 2024 | - | -$17.08 M(+38.1%) | -$48.37 M(+13.4%) |
| Dec 2023 | -$42.64 M | -$12.37 M(+26.1%) | -$42.64 M(+7.6%) |
| Sept 2023 | - | -$9.81 M(+7.6%) | -$39.63 M(+9.0%) |
| June 2023 | - | -$9.11 M(-19.8%) | -$36.34 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$11.36 M(+21.4%) | -$33.06 M(+9.8%) |
| Dec 2022 | -$30.12 M(+115.4%) | -$9.35 M(+43.4%) | -$30.12 M(+45.1%) |
| Sept 2022 | - | -$6.52 M(+12.0%) | -$20.76 M(+45.8%) |
| June 2022 | - | -$5.82 M(-30.8%) | -$14.24 M(+69.2%) |
| Mar 2022 | - | -$8.42 M | -$8.42 M |
| Dec 2021 | -$13.98 M(+398.8%) | - | - |
| Dec 2020 | -$2.80 M | - | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual cash flow from operations?
- What is the all time high annual CFO for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual CFO year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly cash flow from operations?
- What is the all time high quarterly CFO for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly CFO year-on-year change?
- What is Acrivon Therapeutics Common Stock TTM cash flow from operations?
- What is the all time high TTM CFO for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock TTM CFO year-on-year change?
What is Acrivon Therapeutics Common Stock annual cash flow from operations?
The current annual CFO of ACRV is -$42.64 M
What is the all time high annual CFO for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual cash flow from operations is -$2.80 M
What is Acrivon Therapeutics Common Stock annual CFO year-on-year change?
Over the past year, ACRV annual cash flow from operations has changed by -$12.52 M (-41.58%)
What is Acrivon Therapeutics Common Stock quarterly cash flow from operations?
The current quarterly CFO of ACRV is -$17.32 M
What is the all time high quarterly CFO for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly cash flow from operations is -$5.82 M
What is Acrivon Therapeutics Common Stock quarterly CFO year-on-year change?
Over the past year, ACRV quarterly cash flow from operations has changed by -$7.52 M (-76.66%)
What is Acrivon Therapeutics Common Stock TTM cash flow from operations?
The current TTM CFO of ACRV is -$60.67 M
What is the all time high TTM CFO for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high TTM cash flow from operations is -$8.42 M
What is Acrivon Therapeutics Common Stock TTM CFO year-on-year change?
Over the past year, ACRV TTM cash flow from operations has changed by -$21.05 M (-53.11%)